Rockefeller Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.8M | Buy |
323,483
+18,081
| +6% | +$994K | 0.04% | 423 |
|
|
2025
Q1 | $21.6M | Buy |
305,402
+2,902
| +1% | +$205K | 0.05% | 341 |
|
|
2024
Q4 | $19.9M | Buy |
302,500
+35,867
| +13% | +$2.36M | 0.05% | 343 |
|
|
2024
Q3 | $18.7M | Buy |
266,633
+37,805
| +17% | +$2.66M | 0.05% | 358 |
|
|
2024
Q2 | $18.8M | Buy |
228,828
+20,172
| +10% | +$1.66M | 0.05% | 336 |
|
|
2024
Q1 | $18.2M | Buy |
208,656
+18,200
| +10% | +$1.59M | 0.05% | 354 |
|
|
2023
Q4 | $18.4M | Buy |
190,456
+10,760
| +6% | +$1.04M | 0.06% | 305 |
|
|
2023
Q3 | $15.9M | Sell |
179,696
-372,811
| -67% | -$33M | 0.06% | 317 |
|
|
2023
Q2 | $47.9M | Sell |
552,507
-176,939
| -24% | -$15.3M | 0.19% | 137 |
|
|
2023
Q1 | $70.9M | Buy |
729,446
+202,410
| +38% | +$19.7M | 0.31% | 78 |
|
|
2022
Q4 | $54.5M | Sell |
527,036
-492,384
| -48% | -$51M | 0.27% | 87 |
|
|
2022
Q3 | $86.4M | Sell |
1,019,420
-98,181
| -9% | -$8.32M | 0.45% | 48 |
|
|
2022
Q2 | $92.6M | Sell |
1,117,601
-14,734
| -1% | -$1.22M | 0.49% | 41 |
|
|
2022
Q1 | $87.3M | Sell |
1,132,335
-7,502
| -0.7% | -$578K | 0.42% | 53 |
|
|
2021
Q4 | $101M | Sell |
1,139,837
-12,022
| -1% | -$1.06M | 0.47% | 40 |
|
|
2021
Q3 | $89M | Buy |
1,151,859
+338,406
| +42% | +$26.2M | 0.47% | 40 |
|
|
2021
Q2 | $67.9M | Buy |
813,453
+53,161
| +7% | +$4.44M | 0.38% | 52 |
|
|
2021
Q1 | $57.4M | Sell |
760,292
-120,044
| -14% | -$9.06M | 0.39% | 53 |
|
|
2020
Q4 | $77.2M | Buy |
880,336
+4,800
| +0.5% | +$421K | 0.58% | 33 |
|
|
2020
Q3 | $66.6M | Buy |
875,536
+335,439
| +62% | +$25.5M | 0.62% | 26 |
|
|
2020
Q2 | $66.6M | Buy |
540,097
+532,179
| +6,721% | +$65.6M | 0.7% | 25 |
|
|
2020
Q1 | $669K | Buy |
7,918
+3,956
| +100% | +$334K | 0.01% | 548 |
|
|
2019
Q4 | $335K | Buy |
3,962
+74
| +2% | +$6.26K | ﹤0.01% | 649 |
|
|
2019
Q3 | $262K | Buy |
3,888
+3,132
| +414% | +$211K | ﹤0.01% | 573 |
|
|
2019
Q2 | $65K | Sell |
756
-621
| -45% | -$53.4K | ﹤0.01% | 773 |
|
|
2019
Q1 | $122K | Buy |
+1,377
| New | +$122K | ﹤0.01% | 709 |
|